- Home
- NREF vs FDMT Comparison
NREF vs FDMT Comparison
Compare NREF & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NREF
- FDMT
- Stock Information
- Founded
- NREF 2019
- FDMT 2013
- Country
- NREF United States
- FDMT United States
- Employees
- NREF N/A
- FDMT N/A
- Industry
- NREF Real Estate Investment Trusts
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- NREF Real Estate
- FDMT Health Care
- Exchange
- NREF Nasdaq
- FDMT Nasdaq
- Market Cap
- NREF 275.2M
- FDMT 268.6M
- IPO Year
- NREF 2020
- FDMT 2020
- Fundamental
- Price
- NREF $15.63
- FDMT $4.64
- Analyst Decision
- NREF Hold
- FDMT Buy
- Analyst Count
- NREF 4
- FDMT 10
- Target Price
- NREF $14.75
- FDMT $36.33
- AVG Volume (30 Days)
- NREF 27.3K
- FDMT 957.1K
- Earning Date
- NREF 02-27-2025
- FDMT 03-03-2025
- Dividend Yield
- NREF 12.86%
- FDMT N/A
- EPS Growth
- NREF N/A
- FDMT N/A
- EPS
- NREF 1.32
- FDMT N/A
- Revenue
- NREF $73,164,000.00
- FDMT $17,000.00
- Revenue This Year
- NREF N/A
- FDMT N/A
- Revenue Next Year
- NREF $34.61
- FDMT $159.36
- P/E Ratio
- NREF $11.75
- FDMT N/A
- Revenue Growth
- NREF 224.04
- FDMT N/A
- 52 Week Low
- NREF $12.63
- FDMT $4.41
- 52 Week High
- NREF $18.09
- FDMT $36.25
- Technical
- Relative Strength Index (RSI)
- NREF 51.15
- FDMT 40.01
- Support Level
- NREF $15.35
- FDMT $4.41
- Resistance Level
- NREF $15.84
- FDMT $5.42
- Average True Range (ATR)
- NREF 0.36
- FDMT 0.48
- MACD
- NREF 0.03
- FDMT -0.05
- Stochastic Oscillator
- NREF 73.08
- FDMT 9.38
About NREF NexPoint Real Estate Finance Inc.
NexPoint Real Estate Finance Inc is a real estate investment trust. It provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.